Jacob A Orville Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 6 hours ago
Jacob A Orville has an estimated net worth of at least $12.8 million*, as of yesterday. They own 100,403 shares of EXAS stock. They have sold 36,219 shares of EXAS stock since 2021, for an estimated $2.5 million.
Jacob A Orville $EXAS SEC Form 4 Insider Trading
Jacob A Orville has filed a total of 16 insider trades in $EXAS since 2021. Their most recent trade was a sale of 5,000 shares, made on Nov 19, 2025. Their largest trade was a sale of 5,000 shares, made on Nov 19, 2025. We estimate that they now own 100,403 shares of $EXAS, worth an estimated $10.4 million.
Insider Trading at $EXAS
There have been a total of 150 insider trades reported at $EXAS since 2021, with 19,500 shares purchased and 559,166 shares sold. The most active insider traders in $EXAS stock have been Jeffrey Thomas Elliott, Sarah Condella, and Kevin T Conroy. The most recent trade was a sale of 5,000 shares reported by JACOB A ORVILLE (EVP, GM, Screening), made on Nov 19, 2025.
History of Insider Stock Trades by Jacob A Orville
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EXAS
|
Sale | 5,000 | Nov 19, 2025 | Nov. 21, 2025, 6:30 p.m. |
|
EXAS
|
Sale | 102 | May 01, 2024 | May 2, 2024, 7 p.m. |
|
EXAS
|
Sale | 2,154 | Mar 01, 2024 | March 4, 2024, 9:42 p.m. |
|
EXAS
|
Sale | 1,879 | Feb 27, 2024 | Feb. 28, 2024, 8:38 p.m. |
|
EXAS
|
Sale | 1,013 | Feb 22, 2024 | Feb. 23, 2024, 9:03 p.m. |
|
EXAS
|
Sale | 1,078 | Feb 21, 2024 | Feb. 22, 2024, 8:40 p.m. |
|
EXAS
|
Sale | 966 | Feb 15, 2024 | Feb. 16, 2024, 7:26 p.m. |
|
EXAS
|
Sale | 5,000 | May 10, 2023 | May 12, 2023, 4:09 p.m. |
|
EXAS
|
Sale | 5,000 | Feb 28, 2023 | March 1, 2023, 6:22 p.m. |
|
EXAS
|
Sale | 1,832 | Feb 28, 2023 | March 1, 2023, 6:22 p.m. |
|
EXAS
|
Sale | 2,710 | Feb 22, 2023 | Feb. 23, 2023, 5:30 p.m. |
|
EXAS
|
Sale | 954 | Feb 15, 2023 | Feb. 16, 2023, 6:11 p.m. |
|
EXAS
|
Sale | 4,717 | Feb 24, 2022 | Feb. 25, 2022, 7:32 p.m. |
|
EXAS
|
Sale | 1,125 | Feb 23, 2022 | Feb. 24, 2022, 8:10 p.m. |
|
EXAS
|
Sale | 1,749 | Feb 22, 2022 | Feb. 22, 2022, 8 p.m. |
|
EXAS
|
Sale | 940 | Feb 15, 2022 | Feb. 16, 2022, 9:01 p.m. |
$EXAS Executives and Stock Owners with Insider Trades
-
Jeffrey Thomas Elliott, Chief Financial Officer
-
Sarah Condella, EVP, Human Resources
-
Kevin T Conroy, President and CEO
-
Jacob A Orville, General Manager, Screening
-
James Herriott, General Counsel
-
Brian Baranick, Gen. Mgr., Precision Oncology
-
Everett Cunningham, Chief Commercial Officer
-
Sarah Condella, SVP, Human Resources
-
Jacob A Orville, General Manager, New Ventures
-
James Herriott, SVP, General Counsel & Sec
-
Brian Baranick, EVP, GM, Precision Oncology
-
D Scott Coward, Chief Administrative Officer
-
Brian Baranick, EVP, GM., Precision Oncology
-
D Scott Coward, Chief Legal Officer
-
Jacob A Orville, EVP, GM, Screening
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.